BridgeMD
Efficacy of Remimazolam with Fentanyl versus Midazolam with Fentanyl
EU CTIS ID: 2023-503470-21-00
What this study is testing
The overall object of this project is to investigate Remimazolam with Fentanyl compared to Midazolam with Fentanyl for sedation in screening colonoscopy with the primary outcome being total time from start of medication to fulfillment of the discharge criteria. In this way we will examine whether Remimazolam with Fentanyl could create an improvement in procedural sedation by leading to both a shorter procedure as well as shorter recovery time.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age over 18
- Scheduled for elective colonoscopy screening for colon cancer
- Must be able to provide informed written consent.
You likely can't join if
- Requiring general anesthesia.
- Allergy to Midazolam, Remimazolam, opioids or ingredients.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.